150 related articles for article (PubMed ID: 38412922)
1. Dietary macro and micronutrients associated with MASLD: Analysis of a national US cohort database.
Nemer M; Osman F; Said A
Ann Hepatol; 2024; 29(3):101491. PubMed ID: 38412922
[TBL] [Abstract][Full Text] [Related]
2. Clinical profiles and mortality rates are similar for metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease.
Younossi ZM; Paik JM; Stepanova M; Ong J; Alqahtani S; Henry L
J Hepatol; 2024 May; 80(5):694-701. PubMed ID: 38286339
[TBL] [Abstract][Full Text] [Related]
3. Overall and Sex-Specific Associations of Serum Lipid-Soluble Micronutrients with Metabolic Dysfunction-Associated Steatotic Liver Disease among Adults in the United States.
Chai W; Tao MH
Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674932
[TBL] [Abstract][Full Text] [Related]
4. Exploring the landscape of steatotic liver disease in the general US population.
Ciardullo S; Carbone M; Invernizzi P; Perseghin G
Liver Int; 2023 Nov; 43(11):2425-2433. PubMed ID: 37592856
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and factors associated with NAFLD detected by vibration controlled transient elastography among US adults: Results from NHANES 2017-2018.
Zhang X; Heredia NI; Balakrishnan M; Thrift AP
PLoS One; 2021; 16(6):e0252164. PubMed ID: 34081733
[TBL] [Abstract][Full Text] [Related]
6. Food Insecurity, Low Household Income, and Low Education Level Increase the Risk of Having Metabolic Dysfunction-Associated Fatty Liver Disease Among Adolescents in the United States.
Paik JM; Duong S; Zelber-Sagi S; Lazarus JV; Henry L; Younossi ZM
Am J Gastroenterol; 2024 Jun; 119(6):1089-1101. PubMed ID: 38477467
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States.
Gawrieh S; Vilar-Gomez E; Woreta TA; Lake JE; Wilson LA; Price JC; Naggie S; Sterling RK; Heath S; Corey KE; Cachay ER; Ajmera V; Tonascia J; Sulkowski MS; Chalasani N; Loomba R
Aliment Pharmacol Ther; 2024 Mar; 59(5):666-679. PubMed ID: 38158589
[TBL] [Abstract][Full Text] [Related]
8. Prepandemic Prevalence Estimates of Fatty Liver Disease and Fibrosis Defined by Liver Elastography in the United States.
Unalp-Arida A; Ruhl CE
Dig Dis Sci; 2023 Apr; 68(4):1237-1252. PubMed ID: 36173583
[TBL] [Abstract][Full Text] [Related]
9. The prevalence and predictors of metabolic dysfunction-associated steatotic liver disease and fibrosis/cirrhosis among adolescents/young adults.
Perumpail BJ; Manikat R; Wijarnpreecha K; Cholankeril G; Ahmed A; Kim D
J Pediatr Gastroenterol Nutr; 2024 Apr; ():. PubMed ID: 38623942
[TBL] [Abstract][Full Text] [Related]
10. Association of lifestyle behaviors with non-alcoholic fatty liver disease and advanced fibrosis detected by transient elastography among Hispanic/Latinos adults in the U.S.
Heredia NI; Zhang X; Balakrishnan M; Hwang JP; Thrift AP
Ethn Health; 2023 Feb; 28(2):299-312. PubMed ID: 35067116
[TBL] [Abstract][Full Text] [Related]
11. The impact of metabolic syndrome severity on racial and ethnic disparities in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Elsaid MI; Bridges JFP; Mumtaz K; Li N; Sobotka L; Rustgi VK; Paskett ED
PLoS One; 2024; 19(3):e0299836. PubMed ID: 38489287
[TBL] [Abstract][Full Text] [Related]
12. National prevalence estimates for steatotic liver disease and subclassifications using consensus nomenclature.
Lee BP; Dodge JL; Terrault NA
Hepatology; 2024 Mar; 79(3):666-673. PubMed ID: 37732946
[TBL] [Abstract][Full Text] [Related]
13. Association between the skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease: A cross-sectional study of NHANES 2017-2018.
Mai Z; Chen Y; Mao H; Wang L
J Diabetes; 2024 Jun; 16(6):e13569. PubMed ID: 38751375
[TBL] [Abstract][Full Text] [Related]
14. Trends in Oxidative Balance Score and Prevalence of Metabolic Dysfunction-Associated Steatotic Liver Disease in the United States: National Health and Nutrition Examination Survey 2001 to 2018.
Tan Z; Wu Y; Meng Y; Liu C; Deng B; Zhen J; Dong W
Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068789
[TBL] [Abstract][Full Text] [Related]
15. Association between food insecurity and metabolic dysfunction-associated steatotic liver disease/significant fibrosis measured by fibroscan.
Kim D; Perumpail BJ; Cholankeril G; Ahmed A
Eur J Nutr; 2024 Apr; 63(3):995-1001. PubMed ID: 38260997
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of Steatotic Liver Disease Among US Adults with Rheumatoid Arthritis.
Vassilopoulos A; Kalligeros M; Vassilopoulos S; Shehadeh F; Benitez G; Kaczynski M; Lazaridou I; Promrat K; Wands JR; Mylonakis E
Dig Dis Sci; 2024 Mar; 69(3):989-1003. PubMed ID: 38183561
[TBL] [Abstract][Full Text] [Related]
17. Macro- and micronutrients in metabolic (dysfunction) associated fatty liver disease: association between advanced fibrosis and high dietary intake of cholesterol/saturated fatty acids.
Guveli H; Kenger EB; Ozlu T; Kaya E; Yilmaz Y
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e390-e394. PubMed ID: 33731597
[TBL] [Abstract][Full Text] [Related]
18. Association of physical activity with MAFLD/MASLD and LF among adults in NHANES, 2017-2020.
Li M
Wien Klin Wochenschr; 2024 May; 136(9-10):258-266. PubMed ID: 38170220
[TBL] [Abstract][Full Text] [Related]
19. Poor accuracy and sustainability of the first-step FIB4 EASL pathway for stratifying steatotic liver disease risk in the general population.
De Vincentis A; Tavaglione F; Namba S; Kanai M; Okada Y; Kamatani Y; Maurotti S; Pedone C; Antonelli Incalzi R; Valenti L; Romeo S; Vespasiani-Gentilucci U
Aliment Pharmacol Ther; 2024 Jun; 59(11):1402-1412. PubMed ID: 38497224
[TBL] [Abstract][Full Text] [Related]
20. Association between diet soft drink consumption and metabolic dysfunction-associated steatotic liver disease: findings from the NHANES.
Wu Y; Tan Z; Zhen J; Liu C; Zhang J; Liao F; Dong W
BMC Public Health; 2023 Nov; 23(1):2286. PubMed ID: 37985986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
